SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 100 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | +241.7% | 2,350 | +259.9% | 0.00% | – |
| Q3 2021 | $12,000 | -82.4% | 653 | -83.6% | 0.00% | -100.0% |
| Q2 2021 | $68,000 | +750.0% | 3,983 | +1044.5% | 0.00% | – |
| Q1 2021 | $8,000 | +166.7% | 348 | +83.2% | 0.00% | – |
| Q3 2020 | $3,000 | -96.4% | 190 | -96.7% | 0.00% | -100.0% |
| Q2 2020 | $84,000 | – | 5,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |